SUPERBRANCHE Revenue and Competitors

SUPERBRANCHE : Nanomedicine as a breakthrough to treat cancer\n\nWe bring answers to the following issue: intratumoral injection of nanomaterials implying both accessibility and detection of the tumor beforehand.\nWe position ourselves as a producer dedicated to the synthesis of architectured nanomaterials as simple as possible and of controlled size.\nOur modular technology platform presents both therapeutic and diagnosis applications. It consists in a magnetic nanoparticle coated by a tailor made branched architecture.\nThanks to their optimized shape and stability, our compounds are well tolerated and can be administered intravenously,\nthus helping to the early detection and treatment of metastases.\nThe main advantage of the SUPERBRANCHE technology stem from\nour specific processes and synthesis know-how which are at the heart of our innovations.\nSuperbranche is a Biotechnology company characterized by two main activities:\n- the sale of dendrimers and nanoparticles as research products to any laboratory in the field of nanomedicine\n- conducting development partnerships to bring to the clinics targeted diagnostic and image-guided therapy nanomaterials based on its proprietary technology.